The exome sequencing of ten sporadic pancreatic neuroendocrine tumors (PanNETs) identified recurrent and mutually exclusive loss-of-function mutations in DAXX and ATRX for the first time (Jiao et al., 2011). This evidence concerns the gene DAXX and pancreatic neuroendocrine tumor.